RE:Supreme Continues to Put Points on the Board: DeliversI'm going to highlight KEY POINTS from this article with resepct to comparing valuation and how UNDERVALUED this company is. There are similar comparisons that I have been making:
Supreme Cannabis’ financial results demonstrate once again that the company is a player in the cannabis space and punches at the same level as many of the industry heavyweights. Yet, despite its financial strength, the company trades at a significant discount to others.
For example (note: market capitalization figures as at Sept 21, 2018):
- Tilray’s revenue run rate for the most recently disclosed quarter was approximately C$51M, which is slightly over 2.5x Supreme Cannabis ($14.2M) – however, Tilray’s market capitalization ($14.8B) is more than 26x Supreme Cannabis ($0.56B)
- Cronos Group revenue run rate of $13.6M is approximately 5% less than Supreme Cannabis, yet its market capitalization ($2.8B) is more than 5x Supreme Cannabis
- The Green Organic Dutchman has yet to report any revenues, yet its market capitalization ($2.1B) is 3.7x Supreme Cannabis